Veraxa Biotech share price logo

Veraxa Biotech

NASDAQ: VRXA

$0.99

-0.04

(-3.88%)

Live

as on

Veraxa Biotech Stock Performance

as on October 24, 2026 at 6:25 am IST

  • Day's High

    $0.99
    $1.06

    7.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Veraxa Biotech share price movements today

Previous Close
$1.03
Open
$1.04
Volume
300.3K
Market Cap
$149.9M
Day's Low - High
$0.99 - $1.06

Veraxa Biotech Historical Returns

1 Month Return
-25.9 %
3 Month Return
-44.62 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Veraxa Biotech Stock Fundamentals & Key Indicators

Check Veraxa Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$149.9M

EPS (TTM)

0.2496

Dividend Yield

0.00%

PE Ratio (TTM)

50.75

Industry PE ratio

0.00

PEG Ratio

-4571315157469574.00

Return On Equity TTM

5.58%

Veraxa Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veraxa Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$149.9MNA50.750.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Indian Investors' Interest in Veraxa Biotech Stock

Search interest for Veraxa Biotech Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Veraxa Biotech Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
0
0
0
0
0
0
0
0
-2
EBITDA
0
0
0
0
0
0
0
0
-2
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
0
0
1
2
2
2
2
1
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
0
0
1
2
2
2
2
1
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Veraxa Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
0
-1
EBITDA
0
-1
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
4
8
Income Tax Expense
-
-
Net Income
4
8
Net Profit Margin
0.00%
0.00%

Veraxa Biotech Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
1
2
2
2
2
1
0
Operating Cash Flow
-
-
0
0
0
0
0
0
0
Investing Cash Flow
-
-
-254
-254
-
-
-
-
-
Financing Cash Flow
0
-
255
-
-
-
-
-
-
Change in Cash
0
-
0
0
0
0
0
0
0

Veraxa Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
4
8
Operating Cash Flow
0
0
Investing Cash Flow
-254
-
Financing Cash Flow
255
-
Change in Cash
0
0

Global Institutional Holdings in Veraxa Biotech

Check out the Institutions with significant holdings in Veraxa Biotech.

Funds
Holdings
Robert Henry Lynch
0.76%
Merger Fund
0.62%
RiverPark Funds Trust
0.18%
Fidelity
0.02%
Fidelity Concord Street Trust
0.01%

Insights on Veraxa Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 762.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, VRXA stock has moved down by -44.6%

About Veraxa Biotech

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany.
OrganisationVeraxa Biotech
HeadquartersIm Neuenheimer Feld 584, Heidelberg, ZH, 69120, DE
IndustryBiotechnology
CEOChristoph Antz

Key Management of Veraxa Biotech

Name

Title

Mr. Carl von Halem

Principal Financial Officer & Principal Accounting Officer

Dr. Christoph Erkel Ph.D.

Chief Scientific Officer

Dr. Heinz Schwer M.B.A., Ph.D.

Chief Business Officer

Dr. Christoph Antz Ph.D.

Co-Founder, Lead Director & CEO

Mr. Raju Willener

Chief Financial Officer

FAQs

What is Veraxa Biotech share price today?

Veraxa Biotech share price today is $0.99 as on . Veraxa Biotech share today touched a day high of $1.06 and a low of $0.99.

What is the 52 week high and 52 week low for Veraxa Biotech share?

Veraxa Biotech share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Veraxa Biotech stock price today i.e. is trending at $0.99,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Veraxa Biotech's market capitalisation today?

Veraxa Biotech market capitalisation is $0.00T as on .

How to invest in Veraxa Biotech Stock (VRXA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veraxa Biotech on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Veraxa Biotech Stock (VRXA) from India?

Indian investors can start investing in Veraxa Biotech (VRXA) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Veraxa Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Veraxa Biotech share’s latest price of $0.99 as on October 24, 2026 at 12:55 am IST, you will get 10.1010 shares of Veraxa Biotech. Learn more about fractional shares .